Antioxidant and Antimicrobial Potential of Bioactive Compounds Found in Plants

A special issue of Plants (ISSN 2223-7747). This special issue belongs to the section "Phytochemistry".

Deadline for manuscript submissions: closed (31 March 2024) | Viewed by 294

Special Issue Editor


E-Mail Website
Guest Editor
Department of Chemistry Biology and Health Sciences, South Dakota School of Mines & Technology, South Dakota Mines, Rapid City, SD 57701, USA
Interests: plant biochemistry; metabolic engineering
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

As plants are photosynthetic, they are not as limited by ATP availability as most other organisms since they are able to synthesize their own energy directly from light. One advantage this conveys to them is the ability to accumulate compounds that are not essential for central metabolic activity, but that can serve additional roles making them more fit for survival in their individual environments. These myriad natural products, often historically known as secondary metabolites, are a source of uniquely evolved compounds and chemistries that have the potential to interact in new ways and locations as well as with previously unidentified molecular target sites. These myriad libraries of compounds offer a unique opportunity for the discovery of novel bioactive compounds with antimicrobial and/or antioxidant activities. In this special edition of the journal Plants, we present some of the recent advances in discovery and application within the natural products field of study.

Dr. Daniel K. Owens
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Plants is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • natural products
  • secondary metabolites
  • pharmacology
  • nutraceuticals
  • phytochemistry

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop